This page shows the latest Covance news and features for those working in and with pharma, biotech and healthcare.
In addition to Celgene, GNS has previously worked with the likes of J&J, Novartis, Covance and the US National Institutes of Health. .
Takeda has prior experience of the approach however, as it signed high-level deals with Covance and Quintiles in 2011, although the new deal with PRA takes that to a new
One significant departure from the usual M&A activity was Covance's $5.7bn takeover of LabCorp, which completed in February and was unusual in that it married a diagnostic specialist ... The rationale is to combine LabCorp's database of 70 million
Will collaborate on preclinical and clinical stages. LabCorp's Covance and Shandon XuanZhu, a subsidiary of Chinese R&D firm Sihuan Pharmaceutical, have announced a partnership on preclinical and clinical portfolio ... LabCorp announced the acquisition
The strategic-level agreement is reminiscent of Eli Lilly's decision to sell its R&D operations in Greenfield, Indiana, to contract research organisation (CRO) Covance in 2008, with the deal
Covance chairman and CEO Joe Herring will lead LabCorp's Covance division and report directly to King. ... The combined company will remain at LabCorp's headquarters in Burlington, North Carolina, while the Covance division headquarters will still be
More from news
Approximately 5 fully matching, plus 10 partially matching documents found.
Also, on the execution side of R&D, many companies outsource development to contract research organisations (CROs) such as Covance or WuXi Clinical to improve efficiency and reduce costs, especially in
Today, companies have more of a global focus,” says John McDermott, VP, Covance Market Access Services.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
board. Keller brings over three decades of experience to the role, having previously served as chief executive officer (CEO) of drug development company Covance. ... Prior to taking on the CEO role at Covance, she served as group president, R&D
For the past 15 years Lewis worked for Covance, most recently as its group vice president of business development, clinical development and commercialisation services.
Prior to that he spent ten years at Cubist Pharmaceuticals, Biogen and Covance.
Previously, Dr Hoffman served as vice president of medical and scientific affairs at Covance and vice president of global medical affairs and product safety at Hospira.
Alan Morgan joins the data-focused clinical research organisation
More from appointments
Approximately 0 fully matching, plus 10 partially matching documents found.
He has spent his entire career in the healthcare sector, including nearly 12 years at Covance (now Labcorp Drug Development), serving last as Group President of Clinical Development and Commercialization services,
Covance, with headquarters in Princeton, New Jersey, is one of the world’s largest and most comprehensive drug development services companies, with annual revenues greater than $2 billion, employees in more
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...